Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta amyloid fibrils are insoluble, fibrous protein aggregates formed by the self-assembly of amyloid beta (Aβ) peptides. These fibrils are a hallmark of Alzheimer's disease pathology and are found in the extracellular plaques characteristic of the disorder. The formation and accumulation of beta amyloid fibrils are closely linked to neurodegeneration and cell death in Alzheimer's disease. The fundamental structural motif is the cross-β structure, where β-strands run perpendicular to the long axis of the fibril, forming extended β-sheets that stack parallel to each other along the fiber axis. Fibrils consist of several protofilaments, which laterally associate into mature fibers. In Aβ(1–42) fibrils, residues 18–42 form a β-strand–turn–β-strand motif with two intermolecular, parallel, in-register β-sheets. Residues 1–17 remain disordered. Amyloid beta peptides range from 36–43 amino acids; Aβ(1–40) and Aβ(1–42) are most common in human pathology.
Aggregation inhibition (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta Amyloid Fibril (None).